EVOQ® DART-TQ+
Screen Quickly, Validate with Confidence
EVOQ® DART-TQ⁺ with fully integrated DART ion source
EVOQ® DART-TQ⁺ with VIP-HESI source
EVOQ® DART-TQ+ ion path
Fully-integrated DART source
Receive your quote directly from the manufacturer.
EVOQ DART-TQ+ supports rapid and reliable food quality control.
Food testing
We use the EVOQ DART-TQ+ with an integrated DART ion source for chromatography-free approaches supporting high throughput targeted food quality analysis. The rapid DART acquisition time and triple quadrupole mass spectrometry workflow processes datasets efficiently to deliver final and definitive confirmation of adulterants in food samples.
Review Date: 17 Mar 2026 | Bruker Daltonics
Addictive!
Toxicology
Bruker's new EVOQ DART-TQ+ is an excellent platform for instant screening and subsequent quantification in a single run using a single setup. It occupies a small footprint and is very adaptable for all workflows and sample types.
Review Date: 16 Jul 2024 | Bruker Daltonics
With the first and only fully integrated Direct Analysis in Real Time (DART) ion source, the stunning EVOQ® DART-TQ+ system is built for reliable, routine analysis.
Accelerate today, expand tomorrow: EVOQ DART-TQ+ featuring ClinMass now and ClinDART just ahead
In this application note, Bruker Applied Mass Spectrometry demonstrates the EVOQ® DART-TQ+, the only instrument that can switch fast and easily between conventional LC-MS and fully integrated chromatography-free DART-MS technologies.
In collaboration with RECIPE Chemical + Instruments GmbH, this system supports both LC-MS-based ClinMass® kits and future chromatography-free DART-MS-based ClinDART kits – offering unmatched flexibility and throughput.
Rapid chromatography-free quantification by DART-MS/MS
Hear from Zahuindanda Aventura and Lukas Brunner as they introduce the power of Direct Analysis in Real Time (DART) to rapidly quantify multiple panels of drugs in plasma and serum. This rapid, chromatography-free approach allows analysis to take less than 30 seconds to maximize throughput whilst minimizing solvent and gas usage.
Bruker set to bring chromatography-free diagnostics to the masses
Jeff Zonderman, Vice President of Bruker Applied Mass Spectrometry, unveils major strides in clinical diagnostics with the acquisition of RECIPE, a leading provider of mass spectrometry diagnostic kits for small molecule analysis. Combined with Bruker’s DART (Direct Analysis in Real Time) technology, this move enables the development of fully integrated, chromatography-free mass spectrometry workflows tailored to clinical laboratories.
These innovations—centered around the EVOQ DART TQ+ system—promise higher throughput, reduced solvent use, and simplified workflows, making mass spectrometry more accessible to a wider range of labs. Clinical areas of focus include therapeutic drug monitoring, toxicology, and drugs of abuse, with Bruker working toward a future where mass spectrometry functions more like a traditional clinical analyzer.
With a proven track record in simplifying complex instrumentation—like the industry-leading MALDI Biotyper—Bruker is once again breaking down barriers to clinical adoption. By removing chromatography from the equation, the company is delivering greener, faster, and easier diagnostics for the real-world needs of today’s laboratories.
Watch to learn how Bruker is reshaping the future of clinical mass spectrometry.
Bruker tackles drugs of abuse and POPs issues
At ASMS 2024, Bruker made two significant new technology announcements in the field of mass spectrometry, introducing products that can be implemented in diverse areas such as drugs of abuse screening, and persistent organic pollutants (POPs) analysis.
Watch Jeffrey Zonderman, Senior Vice President at Bruker introducing the EVOQ™ DART-TQ+, a new high-end triple quad, highlighted as a greener and more efficient alternative to chromatographic methods, to be used for targeted analysis. The ecTOF™, a high-resolution GC-MS, is also introduced, providing a new solution for untargeted high-resolution screening.
This video was filmed at ASMS 2024. Explore our full coverage of this year's conference >>
